Nucleosome unwrapping and PARP1 allostery drive affinities for chromatin and DNA breaks
Poly(ADP-ribose) polymerase 1 (PARP1) detects DNA strand breaks that occur in duplex DNA and chromatin. Here, correlative optical tweezers and fluorescence microscopy reveal how single molecules of PARP1 identify single-strand breaks (i.e., nicks), undamaged nucleosome core particles (NCP) and NCPs containing DNA nicks. Fluorescently-tagged PARP1 or PARP2 from nuclear extracts binds nicks with nanomolar affinity but does not engage undamaged dsDNA regions. In contrast, PARP1 avidly binds undamaged NCPs, and partial NCP unwrapping induced by DNA tension significantly increases PARP1 on rate and affinity. Catalytically dead PARP1 or EB-47 inhibition greatly increases PARP1 affinity to DNA nicks and undamaged NCP, implicating a mechanism where PARP1 reverse allostery regulates PARP1 retention to undamaged chromatin. We also monitor ADP-ribosylation in real time upon PARP1 binding undamaged or nicked NCPs. These results provide key mechanistic insights into domain allostery and how pharmacological intervention alters PARP1 binding dynamics for therapeutic impacts.
Authors
- Janet Iwasa (ORCID: https://orcid.org/0000-0002-4949-7607)
- Bret Freudenthal (ORCID: https://orcid.org/0000-0003-1449-4710)
- Vera Roginskaya
- Tyler Weaver (ORCID: https://orcid.org/0000-0002-5138-7140)
- Bennett Van Houten (ORCID: https://orcid.org/0000-0002-4009-2478)
- Aafke A. van den Berg (ORCID: https://orcid.org/0000-0003-2991-9478)
- Matthew A. Schaich (ORCID: https://orcid.org/0000-0001-6771-5623)
- Liam P. Leary
- Jennifer A Rakowski
Institutions
- University of Pittsburgh (US)
- University of Utah (US)
- The University of Kansas Cancer Center (US)
- UPMC Health System (US)
- UPMC Hillman Cancer Center (US)
- University of Kansas Medical Center (US)
- University of Pittsburgh Medical Center (US)
- University of Virginia (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1038/s41467-025-67071-2
- Citations
- 2
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences